A detailed history of Janus Henderson Group PLC transactions in Danaher Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,975,399 shares of DHR stock, worth $1.09 Billion. This represents 0.55% of its overall portfolio holdings.

Number of Shares
3,975,399
Previous 3,996,020 0.52%
Holding current value
$1.09 Billion
Previous $998 Million 0.46%
% of portfolio
0.55%
Previous 0.56%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $4.86 Million - $5.53 Million
-20,621 Reduced 0.52%
3,975,399 $993 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $146 Million - $167 Million
-651,394 Reduced 14.02%
3,996,020 $998 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $48.8 Million - $61.5 Million
-263,646 Reduced 5.37%
4,647,414 $1.08 Billion
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $36 Million - $41.1 Million
154,573 Added 3.25%
4,911,060 $1.22 Billion
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $341 Million - $388 Million
1,514,736 Added 46.73%
4,756,487 $1.14 Billion
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $46.7 Million - $54 Million
-194,969 Reduced 5.67%
3,241,751 $817 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $300 Million - $351 Million
-1,244,331 Reduced 26.58%
3,436,720 $912 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $28 Million - $171 Million
-113,205 Reduced 2.36%
4,681,051 $1.21 Billion
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $105 Million - $133 Million
-443,464 Reduced 8.47%
4,794,256 $1.22 Billion
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $86.8 Million - $107 Million
-337,419 Reduced 6.05%
5,237,720 $1.54 Billion
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $46.2 Million - $52.1 Million
158,266 Added 2.92%
5,575,139 $1.83 Billion
Q3 2021

Nov 16, 2021

BUY
$272.21 - $332.43 $19.3 Million - $23.5 Million
70,770 Added 1.32%
5,416,873 $1.65 Billion
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $39.7 Million - $47.9 Million
-176,481 Reduced 3.2%
5,346,103 $1.43 Billion
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $118 Million - $136 Million
554,189 Added 11.15%
5,522,584 $1.24 Billion
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $12.1 Million - $14 Million
57,132 Added 1.16%
4,968,395 $1.1 Billion
Q3 2020

Nov 16, 2020

SELL
$177.16 - $215.33 $61.3 Million - $74.5 Million
-346,186 Reduced 6.58%
4,911,263 $1.06 Billion
Q2 2020

Aug 14, 2020

BUY
$128.7 - $176.83 $9.86 Million - $13.6 Million
76,639 Added 1.48%
5,257,449 $930 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $3.62 Million - $5.04 Million
-29,834 Reduced 0.57%
5,180,810 $717 Million
Q4 2019

Feb 18, 2020

BUY
$133.47 - $153.48 $79.1 Million - $91 Million
592,810 Added 12.84%
5,210,644 $800 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $238 Million - $258 Million
1,759,805 Added 61.57%
4,617,834 $667 Million
Q2 2019

Jul 31, 2019

BUY
$124.88 - $143.73 $264 Million - $304 Million
2,114,293 Added 284.28%
2,858,029 $408 Million
Q1 2019

Apr 30, 2019

BUY
$97.62 - $132.29 $52.4 Million - $71 Million
536,610 Added 259.07%
743,736 $98.2 Million
Q4 2018

Feb 06, 2019

SELL
$94.85 - $109.54 $1.82 Million - $2.11 Million
-19,227 Reduced 8.49%
207,126 $21.4 Million
Q3 2018

Nov 09, 2018

BUY
$98.13 - $108.9 $1 Million - $1.11 Million
10,219 Added 4.73%
226,353 $24.6 Million
Q2 2018

Aug 10, 2018

BUY
$96.1 - $103.24 $175,670 - $188,722
1,828 Added 0.85%
216,134 $21.3 Million
Q1 2018

May 14, 2018

SELL
$92.16 - $103.8 $1.97 Million - $2.22 Million
-21,383 Reduced 9.07%
214,306 $21 Million
Q4 2017

Feb 09, 2018

SELL
$85.26 - $94.62 $21.4 Million - $23.7 Million
-250,970 Reduced 51.57%
235,689 $21.9 Million
Q3 2017

Nov 14, 2017

SELL
$79.29 - $88.45 $9.83 Million - $11 Million
-123,993 Reduced 20.31%
486,659 $0
Q2 2017

Aug 17, 2017

BUY
N/A
610,652
610,652 $51.5 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $201B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.